Drug Research

LinksSchließen

Referenz

Ohtake Y, Sato T, Kobayashi T et al.
Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.

J Med Chem 2012;
55: 7828-7840

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: